IL122751A0 - Use of ipriflavone to reduce the number of CD8 + cells - Google Patents

Use of ipriflavone to reduce the number of CD8 + cells

Info

Publication number
IL122751A0
IL122751A0 IL12275196A IL12275196A IL122751A0 IL 122751 A0 IL122751 A0 IL 122751A0 IL 12275196 A IL12275196 A IL 12275196A IL 12275196 A IL12275196 A IL 12275196A IL 122751 A0 IL122751 A0 IL 122751A0
Authority
IL
Israel
Prior art keywords
ipriflavone
cells
reduce
Prior art date
Application number
IL12275196A
Other languages
English (en)
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of IL122751A0 publication Critical patent/IL122751A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
IL12275196A 1995-07-21 1996-07-16 Use of ipriflavone to reduce the number of CD8 + cells IL122751A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9502198A HU9502198D0 (en) 1995-07-21 1995-07-21 Novel indication
PCT/HU1996/000038 WO1997003664A1 (en) 1995-07-21 1996-07-16 Use of ipriflavone to reduce the number of cd8+ cells

Publications (1)

Publication Number Publication Date
IL122751A0 true IL122751A0 (en) 1998-08-16

Family

ID=10987063

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12275196A IL122751A0 (en) 1995-07-21 1996-07-16 Use of ipriflavone to reduce the number of CD8 + cells

Country Status (22)

Country Link
EP (1) EP0841915A1 (cs)
JP (1) JP2001503371A (cs)
KR (1) KR19990028933A (cs)
CN (1) CN1191483A (cs)
AR (1) AR002905A1 (cs)
AU (1) AU6367096A (cs)
BG (1) BG102182A (cs)
BR (1) BR9610187A (cs)
CA (1) CA2227421A1 (cs)
CZ (1) CZ2798A3 (cs)
EA (1) EA199800146A1 (cs)
EE (1) EE9800020A (cs)
HR (1) HRP960345A2 (cs)
HU (1) HU9502198D0 (cs)
IL (1) IL122751A0 (cs)
MX (1) MX9800603A (cs)
NO (1) NO980127D0 (cs)
PL (1) PL324460A1 (cs)
SK (1) SK3298A3 (cs)
WO (1) WO1997003664A1 (cs)
YU (1) YU42796A (cs)
ZA (1) ZA966079B (cs)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241079B (it) * 1990-03-23 1993-12-29 Chiesi Farma Spa Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
HU212932B (en) * 1993-08-02 1996-12-30 Chinoin Gyogyszer Es Vegyeszet Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition

Also Published As

Publication number Publication date
MX9800603A (es) 1998-04-30
SK3298A3 (en) 1998-07-08
AU6367096A (en) 1997-02-18
CZ2798A3 (cs) 1998-06-17
NO980127L (no) 1998-01-12
WO1997003664A1 (en) 1997-02-06
EE9800020A (et) 1998-08-17
HU9502198D0 (en) 1995-09-28
AR002905A1 (es) 1998-04-29
BG102182A (bg) 1998-08-31
EP0841915A1 (en) 1998-05-20
PL324460A1 (en) 1998-05-25
CN1191483A (zh) 1998-08-26
CA2227421A1 (en) 1997-02-06
HRP960345A2 (en) 1998-02-28
JP2001503371A (ja) 2001-03-13
YU42796A (sh) 1999-03-04
ZA966079B (en) 1998-01-19
NO980127D0 (no) 1998-01-12
BR9610187A (pt) 1998-07-28
KR19990028933A (ko) 1999-04-15
WO1997003664A8 (en) 1999-08-05
EA199800146A1 (ru) 1998-08-27

Similar Documents

Publication Publication Date Title
GB9102759D0 (en) Improvements relating to fire units
AU6703094A (en) Use of flavonoids to treat multidrug resistant cancer cells
GB9518215D0 (en) Improvements relating to telecines
GB9018617D0 (en) Improvements relating to cables
GB9225819D0 (en) Improvements relating to buildings
GB2291329B (en) Improvements to the protection of plants
IL122678A0 (en) Improvements relating to sighting devices
GB9602075D0 (en) Conversion of single to double hull-hull-up technique
IL122751A0 (en) Use of ipriflavone to reduce the number of CD8 + cells
GB2258000B (en) Improvements relating to buildings
GB2268153B (en) Improvements relating to electricity distribution units
GB9508390D0 (en) Improvements relating to construction systems
GB2305445B (en) Improvements relating to buildings
GB9319119D0 (en) Improvements relating to urinal devices
ZA969437B (en) Use of ginkgolides to inhibit glucocorticoid release
TW294904U (en) Structure of windmill arch
TW315718U (en) Structure to adjust the weight of dumb bell
TW302941U (en) Structure of tiles
GB9509950D0 (en) Improvements relating to the sheathing of elongated members
GB2297189B (en) Improvements relating to nuclear reactors
AU126986S (en) Waterproof overpants to secure nappies
GB9315537D0 (en) Aid to rescue
TW307983U (en) Improved structure of the oxygen-supplying waterwheel for cultivation
TW301337U (en) Improved structure of solar energy glasshouse
TW313318U (en) Improved structure of LED